Teva Pharmaceutical Industries Ltd., the world’s largest generic drugmaker, says it is laying off 14,000 workers as part of a global restructuring.
The company said Thursday that the layoffs represent over 25 percent of its global work force. The job cuts are to occur over the next two years, with most of them expected in 2018.
In a letter to employees, Chief Executive Kare Schultz says the restructuring is “crucial to restoring our financial security and stabilizing our business.”
c, a drug for multiple sclerosis; pricing pressure on its core generics business and a $35 billion debt load taken on in its acquisition of the generics business of Allergan.
Teva’s stock has skidded nearly 60 percent this year.
Source:Arabnews
GMT 14:02 2018 Sunday ,02 December
RDIF says $2 billion will be invested in Russian economy from joint Russian-Saudi fundGMT 12:03 2018 Friday ,30 November
Canada on track to sign new free trade deal with US and MexicoGMT 07:59 2018 Wednesday ,21 November
Merkel policies in focus in final debate on draft German budgetGMT 16:57 2018 Wednesday ,31 October
Putin to discuss relations development prospectsGMT 16:04 2018 Monday ,29 October
Russian, Cuban presidents to discuss strategic partnershipGMT 12:57 2018 Saturday ,27 October
"Undeclared war" forces Russia to boost defense spendingGMT 15:45 2018 Friday ,26 October
Medvedev to represent Russia at upcoming APEC summitGMT 14:12 2018 Thursday ,25 October
Saudi Arabia plans to invest in Russian-Chinese Fund soonMaintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Send your comments
Your comment as a visitor